University of Texas Southwestern Medical Center
Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes
Inclusion Criteria: 1. Alive patients with 2 or more visits to the UT Southwestern adult digestive disease clinic within 3 years of the date of trial commencement including at least one visit within 2 years, and 2. An active inflammatory bowel disease-specific medication, and 3. At least one of the following: 1. Inflammatory bowel disease on the active problem list 2. An inflammatory bowel disease invoice diagnosis at least twice in the 3 years prior to trial commencement 3. An inflammatory bowel disease encounter diagnosis at least twice in the 3 years prior to trial commencement…
Participants will undergo initial automated risk stratification to direct tailored follow-up intervals. If exceeding the maximum time interval, participants in the intervention arm will be contacted by scheduling personnel using a standardized protocol to schedule a follow-up visit. In contrast, patients in the control arm who are overdue will not be made known to any staff and will not be proactively contacted, instead continuing to be managed according to standard of care. To maximize generalizability and understanding among staff and patients, risk stratification will be based on inflammatory bowel disease medication use.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.